Edoxaban for stroke prevention in atrial fibrillation and factors associated with dosing: patient characteristics from the prospective observational ETNA-AF-China registry.
Guo X, Du J, Yang Y, Wu M, Ou W, Han X, Wang Z, Jin J, Zhang P, Zhang Z, Chen G, Long M, Yin G, Liu T, Wang X, Li D, Chen M, Dong Y, Lai C, Zhang X, Yi Y, Xiang J, Chen C, Unverdorben M, Ma C; ETNA-AF-China Investigators.
Guo X, et al. Among authors: liu t.
Sci Rep. 2024 Feb 2;14(1):2778. doi: 10.1038/s41598-024-51776-3.
Sci Rep. 2024.
PMID: 38307927
Free PMC article.